Federal contract award

75N95022P00542

TOLERABILITY STUDIES OF CANDIDATE AD DRUGS AND EFFICACY OF POLY(L-LYSINE SUCCINYLATED)-HYDROXYCHLOROQUINE (PLS-HCQ) IN A TRANSGENIC AD MOUSE MODEL

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIDA
NAICS541380 — Testing Laboratories and Services
PSCQ301 — Reference Laboratory Testing
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$249.0K
Current contract value$249.0K
Potential contract value / ceiling$249.0K
Start dateSep 30, 2022
Current end dateMay 2, 2025
Potential end dateMay 2, 2025
Latest award activityMay 2, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 2, 2025P00002$0FY26 UDO INITIATIVE - EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE TOLERABILITY STUDIES OF CANDIDATE
Dec 6, 2024P00001$0TOLERABILITY STUDIES OF CANDIDATE AD DRUGS AND EFFICACY OF POLY(L-LYSINE SUCCINYLATED)-HYDROXYCHLOROQUINE (PLS-HCQ) IN A TRANSGENIC AD MOUSE MODEL
Sep 12, 20220$249.0KTOLERABILITY STUDIES OF CANDIDATE AD DRUGS AND EFFICACY OF POLY(L-LYSINE SUCCINYLATED)-HYDROXYCHLOROQUINE (PLS-HCQ) IN A TRANSGENIC AD MOUSE MODEL

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Rashiid CumminsContactrashiid.cummins@nih.govSourceJul 12, 2022
Rashiid CumminsContactrashiid.cummins@nih.govSourceJun 21, 2022

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.